Teva (TEVA) Hits Multi-Year High as Q3 Strengthens FY25 Profitability Expectations
Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands Austedo, Ajovy, and Uzedy, with sales jumping by 38 percent, 19 percent, and...






